Baxter International (BAX) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $25.76, +3.87% vs the prior close of $24.80.
- Volume 4.51M shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BAX jumps 3.9% to $25.76, a 1-month high. Closed at $25.76, +3.87% vs the prior close of $24.80. Day range $25.22–$25.89, opened at $25.25.
BAX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — BAX jumps 3.9% to $25.76, a 1-month high
- Closed at $25.76, +3.87% vs the prior close of $24.80. Day range $25.22–$25.89, opened at $25.25.
- Volume was 4.51M shares, 0.7x its 50-day average of 6.20M.
- Price is +2.9% vs its 50-day average ($25.04) and +22.2% vs its 200-day average ($21.08).
- 52-week range $15.73–$30.00; today's close sits at 70% of that range, 14.1% below the 52-week high.
Oct 14, 2026 — BAX dips 0.4% to $24.80
- Closed at $24.80, -0.36% vs the prior close of $24.89. Day range $24.59–$25.04, opened at $24.86.
- Volume was 5.21M shares, 0.8x its 50-day average of 6.30M.
- Price is -1.1% vs its 50-day average ($25.07) and +17.9% vs its 200-day average ($21.04).
- 52-week range $15.73–$30.00; today's close sits at 64% of that range, 17.3% below the 52-week high.
Oct 13, 2026 — BAX rises 0.4% to $24.89, a 1-month high, 3 up days in a row
- Closed at $24.89, +0.44% vs the prior close of $24.78. Day range $24.52–$25.26, opened at $25.06.
- Volume was 3.25M shares, 0.5x its 50-day average of 6.44M — lighter than usual.
- Price is -1.0% vs its 50-day average ($25.14) and +18.4% vs its 200-day average ($21.02).
- 52-week range $15.73–$30.00; today's close sits at 64% of that range, 17.0% below the 52-week high.
- That makes 3 straight gains.
Oct 12, 2026 — BAX rises 1.8% to $24.78, a 1-month high
- Closed at $24.78, +1.77% vs the prior close of $24.35. Day range $24.34–$24.85, opened at $24.44.
- Volume was 5.23M shares, 0.8x its 50-day average of 6.53M.
- Price is -1.7% vs its 50-day average ($25.21) and +18.1% vs its 200-day average ($20.99).
- 52-week range $15.73–$30.00; today's close sits at 63% of that range, 17.4% below the 52-week high.
Oct 9, 2026 — BAX rises 1.9% to $24.35
- Closed at $24.35, +1.88% vs the prior close of $23.90. Day range $23.84–$24.47, opened at $23.93.
- Volume was 3.01M shares, 0.4x its 50-day average of 6.92M — lighter than usual.
- Price is -3.5% vs its 50-day average ($25.24) and +16.2% vs its 200-day average ($20.96).
- 52-week range $15.73–$30.00; today's close sits at 60% of that range, 18.8% below the 52-week high.
Oct 8, 2026 — BAX ends flat (-0.3%) to $23.90
- Closed at $23.90, -0.29% vs the prior close of $23.97. Day range $23.50–$24.14, opened at $23.97.
- Volume was 7.56M shares, 1.1x its 50-day average of 6.96M.
- Price is -5.5% vs its 50-day average ($25.28) and +14.2% vs its 200-day average ($20.93).
- 52-week range $15.73–$30.00; today's close sits at 57% of that range, 20.3% below the 52-week high.
Oct 7, 2026 — BAX dips 1.6% to $23.97
- Closed at $23.97, -1.60% vs the prior close of $24.36. Day range $23.82–$24.60, opened at $24.20.
- Volume was 4.77M shares, 0.7x its 50-day average of 7.00M.
- Price is -5.3% vs its 50-day average ($25.30) and +14.7% vs its 200-day average ($20.91).
- 52-week range $15.73–$30.00; today's close sits at 58% of that range, 20.1% below the 52-week high.
Oct 6, 2026 — BAX rises 0.6% to $24.36
- Closed at $24.36, +0.58% vs the prior close of $24.22. Day range $23.92–$24.42, opened at $24.32.
- Volume was 6.52M shares, 0.9x its 50-day average of 6.98M.
- Price is -3.7% vs its 50-day average ($25.31) and +16.7% vs its 200-day average ($20.88).
- 52-week range $15.73–$30.00; today's close sits at 60% of that range, 18.8% below the 52-week high.
Oct 5, 2026 — BAX jumps 3.1% to $24.22
- Closed at $24.22, +3.11% vs the prior close of $23.49. Day range $23.24–$24.29, opened at $23.46.
- Volume was 10.16M shares, 1.5x its 50-day average of 6.88M.
- Price is -4.2% vs its 50-day average ($25.29) and +16.1% vs its 200-day average ($20.86).
- 52-week range $15.73–$30.00; today's close sits at 59% of that range, 19.3% below the 52-week high.
Oct 2, 2026 — BAX dips 0.6% to $23.49
- Closed at $23.49, -0.63% vs the prior close of $23.64. Day range $23.40–$23.85, opened at $23.84.
- Volume was 4.81M shares, 0.7x its 50-day average of 6.87M.
- Price is -7.0% vs its 50-day average ($25.25) and +12.8% vs its 200-day average ($20.83).
- 52-week range $15.73–$30.00; today's close sits at 54% of that range, 21.7% below the 52-week high.
BAX latest news & SEC filings
Every SEC filing by or about BAX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · 3 — Initial insider ownership statement (Form 3)
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 18, 2026 · 3 — Initial insider ownership statement (Form 3)
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 3, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 3, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 3, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 19, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 18, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 8.01 — Reported other events the company considers important.
Aug 4, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 4, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 30, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $2.96B (prior year $2.81B) (+5.3% vs Jun 30, 2025)
- Net income: $126.00M (prior year $91.00M) (+38.5% vs Jun 30, 2025)
- Diluted EPS: $0.24 (prior year $0.18) (+33.3% vs Jun 30, 2025)
Jul 30, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 8.01 — Reported other events the company considers important.
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 14, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade BAX
- Last results release: Jul 30, 2026 (8-K Item 2.02). Previous ones: Apr 30, 2026, Feb 12, 2026, Oct 30, 2025. Based on that rhythm, the next report is likely around Oct 29, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.25% (largest 3.9%).
- Liquidity: about 6.82M shares (≈$175.74M) trade per day on average.
- 52-week position: $25.76 vs a range of $15.73–$30.00 (70% of the range).
- Dividends: last ex-dividend date Aug 28, 2026 ($0.01/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Aug 19, 2026; 8-K Aug 18, 2026; 8-K Aug 4, 2026.
- Share count: 517.00M shares outstanding (Jul 23, 2026), +0.7% vs a year earlier.
- Listing: NYSE · industry: Surgical & Medical Instruments & Apparatus.
BAX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 25.25 | 25.89 | 25.22 | 25.76 | 4.51M |
| Oct 14, 2026 | 24.86 | 25.04 | 24.59 | 24.80 | 5.21M |
| Oct 13, 2026 | 25.06 | 25.26 | 24.52 | 24.89 | 3.25M |
| Oct 12, 2026 | 24.44 | 24.85 | 24.34 | 24.78 | 5.23M |
| Oct 9, 2026 | 23.93 | 24.47 | 23.84 | 24.35 | 3.01M |
| Oct 8, 2026 | 23.97 | 24.14 | 23.50 | 23.90 | 7.56M |
| Oct 7, 2026 | 24.20 | 24.60 | 23.82 | 23.97 | 4.77M |
| Oct 6, 2026 | 24.32 | 24.42 | 23.92 | 24.36 | 6.52M |
| Oct 5, 2026 | 23.46 | 24.29 | 23.24 | 24.22 | 10.16M |
| Oct 2, 2026 | 23.84 | 23.85 | 23.40 | 23.49 | 4.81M |
| Oct 1, 2026 | 23.95 | 24.04 | 23.48 | 23.64 | 7.38M |
| Sep 30, 2026 | 23.50 | 24.10 | 23.37 | 24.00 | 8.73M |
| Sep 29, 2026 | 23.29 | 23.72 | 23.15 | 23.48 | 6.69M |
| Sep 28, 2026 | 23.21 | 23.82 | 23.11 | 23.49 | 6.17M |
| Sep 25, 2026 | 23.43 | 23.71 | 23.20 | 23.37 | 6.57M |
| Sep 24, 2026 | 23.48 | 23.76 | 23.20 | 23.48 | 7.35M |
| Sep 23, 2026 | 23.59 | 24.30 | 23.45 | 23.49 | 9.44M |
| Sep 22, 2026 | 23.21 | 23.87 | 23.21 | 23.68 | 7.36M |
| Sep 21, 2026 | 22.99 | 23.08 | 22.56 | 22.93 | 11.75M |
| Sep 18, 2026 | 23.05 | 23.16 | 22.71 | 22.80 | 9.97M |
About Baxter International
Baxter International (BAX) is listed on the NYSE and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in DEERFIELD, IL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 10456.
BAX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| William A. Ii Ampofo | Director | May 7, 2026 |
| Jeffrey A Craig | Director | May 7, 2026 |
| Andrew P. Hider | President and CEO | Sep 3, 2026 |
| Patricia Morrison | Director | May 7, 2026 |
| Michael R. Mcdonnell | Director | May 7, 2026 |
| Nancy M Schlichting | Director | May 7, 2026 |
| David Brent Shafer | Chair of the Board | May 7, 2026 |
| Amy Mcbride Wendell | Director | May 7, 2026 |
| David S. Wilkes | Director | May 7, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Cynthia Carlisle | Executive Vice President, CHRO | Mar 3, 2026 |
| Julie Foster | President, Front Line Care | Sep 3, 2026 |
| Joel T. Grade | EVP and CFO | Mar 10, 2026 |
| Bernard Heine | AVP, Finance InterimCAO&Cntrlr | Sep 18, 2026 |
| Andrew P. Hider | President and CEO | Sep 3, 2026 |
| Jeanne K Mason | EVP, Chief HR Officer | Dec 16, 2025 |
| Reazur Rasul | EVP,Group Pres,Healthcare | Mar 10, 2026 |
| David S. Rosenbloom | EVP and General Counsel | Mar 10, 2026 |
| Maria Cecilia Soriano | Group Pres., ITT & Pharma. | Mar 10, 2026 |
| James Teaff | President, CCS | Sep 3, 2026 |
| Steven P. Wallace | President, Adv. Surgery | Jun 3, 2026 |
| Anita A Zielinski | SVP, Interim CFO, CAO & Cntrlr | Jun 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
BAX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $11.24B | $-957.00M | -1.87 | $845.00M |
| Dec 31, 2024 | $10.64B | $-649.00M | -1.27 | $1.02B |
| Dec 31, 2023 | $10.36B | $2.66B | 5.23 | $1.73B |
| Dec 31, 2022 | $10.06B | $-2.43B | -4.83 | $1.21B |
| Dec 31, 2021 | $12.15B | $1.28B | 2.53 | $2.22B |
Latest balance sheet: total assets $19.79B, total liabilities $13.61B, cash $2.15B (as of Jun 30, 2026).
BAX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 30, 2026 | 8-K Item 2.02 (results) | $26.75 |
| Apr 30, 2026 | 8-K Item 2.02 (results) | $17.58 |
| Feb 12, 2026 | 8-K Item 2.02 (results) | $18.71 |
| Oct 30, 2025 | 8-K Item 2.02 (results) | $19.16 |
| Jul 31, 2025 | 8-K Item 2.02 (results) | $21.76 |
| May 1, 2025 | 8-K Item 2.02 (results) | $30.67 |
| Feb 20, 2025 | 8-K Item 2.02 (results) | $33.44 |
| Feb 3, 2025 | 8-K Item 2.02 (results) | $31.64 |
| Nov 8, 2024 | 8-K Item 2.02 (results) | $34.64 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
| Feb 8, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on BAX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.